|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Trillsch, Fabian; Mahner, Sven; Ataseven, Beyhan; Asher, Rebecca; Aryal, Nanda; Dubot, Coraline; Clamp, Andrew; Penson, Richard T.; Oza, Amit; Amit, Amnon; Huzarski, Tomasz; Casado, Antonio; Scambia, Giovanni; Friedlander, Michael; Colombo, Nicoletta; Fujiwara, Keiichi; Sonke, Gabe S.; Denys, Hannelore; Lowe, Elizabeth S.; Lee, Chee K. und Pujade-Lauraine, Eric
(2022):
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
In: Gynecologic Oncology, Bd. 165, Nr. 1: S. 40-48
2020
Ray-Coquard, Isabelle; Hatcher, Helen; Bompas, Emmanuelle; Casado, Antonio; Westermann, Annekke; Isambert, Nicolas; Casali, Paolo Giovanni; Pratap, Sarah; Stark, Daniel; Valverde, Claudia; Anand, Anjana; Huizing, Manon; Floquet, Anne; Lindner, Lars; Hermes, Barbara; Seddon, Beatrice; Coens, Corneel; Jones, Robin und Reed, Nick
(2020):
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment (EORTC62113).
In: International Journal of Gynecological Cancer, Bd. 30, Nr. 10: S. 1633-1637